Of US women between the ages of 15 and 49, 64.9% use some form of contraception, and the use of long-acting reversible contraceptives is increasing; people with prolonged opioid use have an increased risk for cardiovascular problems, but they are also more likely to develop major surgery complications; there are an estimated 11 million undocumented immigrants in the United States, and they struggle to receive basic medical care.
Of US women between the ages of 15 and 49, 64.9% use some form of contraception, and the use of long-acting reversible contraceptives (LARCs) is increasing. According to The New York Times, more than 10% of women use LARCs, which are hormone-releasing rods placed under the skin or intrauterine devices. From 2011 to 2015, 8% of women were using LARCs, which increased to 11.3% in the 2015 to 2017 period. The most common form of contraception is female sterilization (18.6%), followed by oral contraceptives (12.6%).
People with prolonged opioid use have an increased risk for cardiovascular problems, but they are also more likely to develop major surgery complications. While mortality rates are similar between patients with and without opioid use disorder (OUD) who underwent heart surgery, those with OUD were more likely to have serious complications, reported Reuters. These surgical complications result in longer hospital stays and higher costs. The research in JAMA Surgery also found that people with OUD having heart surgery were almost 2 decades younger than patients having heart surgery without OUD.
There are an estimated 11 million undocumented immigrants in the United States, and they struggle to receive basic medical care. A new article in Vice highlighted the hurdles these immigrants face when seeking care. In addition to approximately 40% being uninsured, they have been seeking less care as the immigration debate continues. The article follows one woman’s journey for a doctor’s appointment for an infection in her foot due to a growing ulcer, and the challenges she faces: traveling 3 hours to the doctor’s office, a language barrier, paying for public transportation, and more.
6 Blood Biomarkers Identified to Predict CVD Risk in Patients With Rheumatoid Arthritis
March 15th 2024Baseline levels of serum amyloid A, C‐reactive protein, soluble tumor necrosis factor receptor 1, adiponectin, YKL‐40, and osteoprotegerin could be used to predict a rise in arterial inflammation.
Read More
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
FDA Approves Semaglutide to Prevent Heart Events in Patients With CVD and Excess Weight
March 8th 2024The FDA added another indication for semaglutide (Wegovy), expanding its use to reduce the risk of cardiovascular death, heart attack, or stroke in adults who have cardiovascular disease (CVD) and overweight or obesity.
Read More
Experimental RNA Therapy Significantly Reduces Blood Pressure up to 6 Months, Study Says
February 18th 2024Researchers said these findings confirm that zilebesiran can significantly reduce serum angiotensinogen levels, leading to sustained reductions in blood pressure over a 24-hour period, even 6 months post-treatment, though more research is needed for longer-term use.
Read More
Registry Reveals Sex Differences in HoFH Diagnosis, Treatment, and Cardiovascular Outcomes
February 15th 2024Although the prevalence of myocardial infarction (MI) was doubled among men compared with women with homozygous familial hypercholesterolemia (HoFH), both sexes had similar ages at first MI.
Read More